CorMedix CRMD
NASDAQ CRMD
$8.20 -0.03 (-0.36%)
At close: Aug 21, 2026 · 4:00 PM EDT

CorMedix (CRMD) Net Margin (2013 - 2026)

CorMedix (CRMD) posted Net Margin of 9.16% for Q4 2025, down 108.8% sequentially from 104.08% in Q3 2025, and down 5230.0% YoY from 0.18% in Q4 2024.

CorMedix (CRMD) Net Margin (2013 - 2026) Analysis & Trends

CorMedix has reported Net Margin for 12 years, with the latest figure at 9.16% in Q4 2025.

  • Quarterly Net Margin fell 5230.0% year-over-year to 9.16% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 44.68% (up 8589.0% YoY) and the FY2025 annual result came in at 44.03%, up 8528.0% from the prior year.
  • Net Margin eased to 9.16% in Q4 2025 per CRMD's latest filing, from 104.08% in the prior quarter.
  • Over five years, Net Margin peaked at 91671.03% in Q1 2022 and troughed at 100538.67% in Q3 2022.
  • A 4-year average of 4498.39% and a median of 52.82% in 2025 frame the typical range for Net Margin.
  • The widest YoY moves for Net Margin: up 8351341 bps in 2022, down 12311796 bps in 2022.
  • Over 4 years, Net Margin stood at 17141.29% in 2021, then tumbled by 61 bps to 27637.7% in 2022, then surged by 100 bps to 43.14% in 2024, then plunged by 121 bps to 9.16% in 2025.
  • According to Business Quant data, Net Margin over the past three periods registered 9.16%, 104.08%, and 55.0% for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 32.99%
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 30.23%
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 31.16%
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -539.31%
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 13.90%
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 12.74%
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -16.51%
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -3.12%
9 Royalty Pharma 27.27 Bn 26.43 Bn - 12.09%
10 CorMedix 645.20 Mn 388.51 Mn 77.13 Mn 25.50%

Historic Data

Download Data
DateValue
Jun 30, 2026 25.50%
Dec 31, 2025 -9.16%
Sep 30, 2025 104.08%
Jun 30, 2025 55.00%
Mar 31, 2025 52.82%
Dec 31, 2024 43.14%
Sep 30, 2024 -24.28%
Jun 30, 2024 -1,754.86%
Dec 31, 2022 -27,637.70%
Sep 30, 2022 -100,538.67%
Jun 30, 2022 35,759.66%
Mar 31, 2022 91,671.03%
Dec 31, 2021 -17,141.29%
Sep 30, 2021 22,579.29%
Jun 30, 2021 56,159.20%
Mar 31, 2021 8,157.62%
Dec 31, 2020 -68,075.68%
Sep 30, 2020 7,095.25%
Jun 30, 2020 23,110.14%
Mar 31, 2020 7,562.05%